Adaltis, Inc., a Montreal maker of in-vitro diagnostic systems, is concentrating its focus – both operationally and in terms of revenue – on China. The company has been transferring its manufacturing to the Shanghai while it also looks to the China market to increase its revenues. More details...

Stock Symbol: (TSX: ADS)